NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 4 - Central nervous system 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

04.03.04 Other antidepressant drugs

Agomelatine (Valdoxan®)

RED
Restricted Drug Restricted

For initiation and ongoing prescribing by ELFT Specialist only.

 

Entry reviewed: June 2022

Bupropion (Zyban®)
(Modified release tablet 150mg)

RED
Formulary

 Off-label use for treatment-resistent depression.

Prescribing support document is in development [Last updated October 2025]

Entry reviewed: May 2025

Duloxetine 30mg, 60mg Capsules
(GAD or depression)

Formulary

Specialist to advise for GAD or depression

 

NB: The 90mg and 120mg are high cost NON FORMULARY strengths.

NB: The 20mg and 40mg are only licensed for stress incontinence and are Non-Formulary for the above indications.

 

Entry reviewed: May 2023

Duloxetine 30mg, 60mg Capsules
(For management of Chronic Non-Cancer Pain in Adults)

Formulary

Off-label use in line with Primary Care Guidelines for the Management of Chronic Non-Cancer Pain in Adults

 

NB: The 90mg and 120mg are high cost NON FORMULARY strengths.

NB: The 20mg and 40mg are only licensed for stress incontinence and are Non-Formulary for the above indications.

 

Entry reviewed: May 2023

Mirtazapine

Formulary

15mg & 30mg Tablets
15mg, 30mg & 45mg Orodispersible Tablets

 

NB: Oral solution is 50x more expensive than orodispersible tablets.
Use orodispersible tablets for patients with swallowing difficulties and for enteral tube administration.

Reboxetine (Edronex®)
(Tablets)

Restricted Drug Restricted

For initiation by Mental Health specialist from ELFT only

 

 

Venlafaxine oral
(For licensed indications)

Formulary

37.5mg & 75mg tablets
37.5mg modified release tablets
75mg & 150mg modified release capsules

 

Entry reviewed: June 2022

 

Venlafaxine oral
(for narcolepsy and cataplexy)

Formulary

37.5mg & 75mg tablets
37.5mg modified release tablets
75mg & 150mg modified release capsules

To be used in line with EoE PAC guidance for narcolepsy and cataplexy. Refer to Shared Care Guideline associated with sleep centre attended by the patient.

 

Entry reviewed: June 2022

 

Vortioxetine

Restricted Drug Restricted
Restricted - only to be initiated by a Consultant Psychiatrist for treating major depressive episodes in accordance with NICE TA367.

5mg, 10mg & 20mg Film Coated Tablets

Flupentixol

Formulary

500microgram, 1mg, 3mg Tablets

Entry reviewed July 2025

Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.